Fundamental - Factsheet
Help
BIOCEPT INC
BIOCEPT
Updated on 26 Feb 2021 (End of trading day)
Last (USD): 6.030 |
Change: -0.210 |
High: 6.390 |
Change (%): -3.37 |
Low: 5.640 |
Open |
6.260 |
Yesterday's Close |
6.24 |
Buy Price |
- |
Sell Price |
- |
Buy Volume (share) |
- |
Sell Volume (share) |
- |
Cumulative Volume (share) |
329,387 |
Cumulative Value |
|
Key Statistics
(USD) a
|
-1.88551 |
(USD) e |
-1.89950 |
(USD) b |
1.5939 |
a
|
- |
f |
- |
b |
3.7832 |
(USD) d
|
- |
Cash In Hand
(USD) g |
1.2584 |
Issued & Paid-up Shares
c |
13,396,700 |
(%)
d
|
- |
Price / Cash In Hand
g |
4.792 |
Treasury Shares h |
- |
Market Cap (M) |
80.782 |
Enterprise Value (M) |
66.629 |
|
3 |
Exchange Code |
BIOC |
Par Value (
$
)
|
n.a. |
52 Weeks Volatility (%) |
130.63 |
|
100.0 |
Sector & Industry |
Health Services
-
Medical/Nursing Services |
Notes:
-
Based on latest Full Year results announcement, adjusted for the current number of shares.
-
Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
-
-
Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
-
Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
-
Based on Trailing EPS.
-
Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
-
Rounded to the nearest thousand. Updated on 13 Jul 2015.
Peer Comparison
Type |
Name |
Market |
Market Cap (M)a |
b
|
c
|
d
|
(%)d
|
Reference |
BIOCEPT INC |
NASDAQ |
80.782 |
- |
- |
3.7832 |
- |
Industry |
Medical/Nursing Services
|
NASDAQ |
2,398.742 |
- |
- |
9.6890 |
0.012 |
Local Peer |
GUARDANT HEALTH INC |
NASDAQ |
14,780.846 |
- |
- |
- |
- |
Local Peer |
NATERA INC |
NASDAQ |
10,009.628 |
- |
- |
18.4898 |
- |
Local Peer |
AMEDISYS INC |
NASDAQ |
8,331.694 |
- |
- |
- |
- |
Local Peer |
1LIFE HEALTHCARE INC |
NASDAQ |
6,388.765 |
- |
- |
11.7547 |
- |
Local Peer |
LHC GROUP INC |
NASDAQ |
5,740.637 |
59.970 |
55.724 |
3.8408 |
- |
Local Peer |
NEOGENOMICS INC |
NASDAQ |
5,960.432 |
- |
- |
- |
- |
Local Peer |
ACADIA HEALTHCARE |
NASDAQ |
4,915.874 |
45.132 |
49.019 |
1.8859 |
- |
Local Peer |
SMILEDIRECTCLUB INC |
NASDAQ |
4,481.474 |
- |
- |
14.2734 |
- |
Local Peer |
ENSIGN GROUP INC |
NASDAQ |
4,486.141 |
26.315 |
26.315 |
5.4838 |
0.247 |
Local Peer |
OPTION CARE HEALTH INC |
NASDAQ |
3,450.266 |
- |
- |
3.4729 |
- |
Local Peer |
BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A |
NASDAQ |
3,112.404 |
- |
- |
8.3700 |
- |
Local Peer |
FULGENT GENETICS INC |
NASDAQ |
2,457.945 |
- |
51.522 |
13.1472 |
- |
Other Local Peers |
GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), CASTLE BIOSCIENCES INC (NASDAQ), ADDUS HOMECARE CORP (NASDAQ), PENNANT GROUP INC (NASDAQ), TIVITY HEALTH INC (NASDAQ), ONTRAK INC (NASDAQ), RADNET INC (NASDAQ), APRIA INC (NASDAQ), BIODESIX INC (NASDAQ), CARDIFF ONCOLOGY INC (NASDAQ), PROGENITY INC (NASDAQ), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), AKUMIN INC (NASDAQ), EXAGEN INC (NASDAQ), SANARA MEDTECH INC (NASDAQ), APTINYX INC (NASDAQ), OPTINOSE INC (NASDAQ), ONCOSEC MEDICAL INCORPORATED (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), NOVO INTEGRATED SCIENCES INC (NASDAQ), PRO-DEX INC (NASDAQ), GUARDION HEALTH SCIENCES INC (NASDAQ), GBS INC (NASDAQ), IMAC HOLDINGS INC (NASDAQ) |
Global Peer |
JD HEALTH |
HKEx |
451,543.666 |
- |
- |
-70.6774 |
- |
Global Peer |
FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV |
NYSE |
20,208.720 |
- |
- |
- |
- |
Global Peer |
PA GOODDOCTOR |
HKEx |
128,611.209 |
- |
- |
6.8510 |
- |
Global Peer |
OAK STREET HEALTH INC |
NYSE |
12,767.397 |
- |
- |
27.7368 |
- |
Global Peer |
SONIC HEALTHCARE |
ASX |
15,161.227 |
28.728 |
15.943 |
2.6008 |
2.664 |
Global Peer |
DAVITA INC |
NYSE |
11,173.022 |
14.264 |
14.264 |
8.0755 |
- |
Global Peer |
INVITAE CORP |
NYSE |
7,449.412 |
- |
- |
3.7822 |
- |
Global Peer |
CHEMED CORP |
NYSE |
7,101.901 |
22.231 |
22.231 |
7.8805 |
- |
Global Peer |
JXR |
HKEx |
43,652.197 |
93.981 |
110.595 |
5.2614 |
0.377 |
Global Peer |
NH HEALTH-B |
HKEx |
25,097.958 |
- |
- |
-26.2399 |
- |
Other Global Peers |
HEALIUS LTD (ASX), MEDNAX INC (NYSE), US PHYSICAL THERAPY (NYSE), SVH (SET), RAM (SET), KPJ (Bursa), UM HEALTHCARE (HKEx), C-MER EYE (HKEx), HANGER INC (NYSE), Metro Healthcare Indonesia Tbk. (IDX), OCEANIA HEALTHCARE LTD (ASX), GLOBAL CORD BLOOD CORPORATION (NYSE), VIRTUS HEALTH LIMITED (ASX), EUROEYES (HKEx), CRH MEDICAL CORP (NYSE American), CLOVER CORP (ASX), SILK LASER AUSTRALIA LTD (ASX), BARD1 LIFE SCIENCES LTD (ASX), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), HEALTHIA LTD (ASX), RAILY AESMED (HKEx), OPTIMAX (Bursa), UMP (HKEx), ORTHOCELL LIMITED (ASX), Clearbridge (SGX), CAPITAL SENIOR LIVING CORP (NYSE), Cordlife (SGX), Asian Healthcare (SGX), Diagnos Laboratorium Utama Tbk. (IDX), MHCARE (Bursa), KDH (SET), HC Surgical (SGX), HUMAN HEALTH (HKEx), D (SET), Sing Paincare (SGX), CHINA HEALTH (HKEx), TOTAL BRAIN LTD (ASX), Alliance HC (SGX), Medinex (SGX), AsiaMedic (SGX), LIFESPOT HEALTH LTD (ASX), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), SMILE (Bursa), RHT HealthTrust (SGX), REPUBLIC HC (HKEx), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX), TOPVISN (Bursa) |
Notes:
-
For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is
the average market cap for that industry/index.
-
Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the
industry/index.
-
Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all
companies in the industry/index.
-
Industry/Index Dividend Yield is
calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
-
For Industry/Index calculation, data for foreign currency denominated companies will be converted to the
main market currency using the latest exchange rate.
-
Industry/Index/Peers data is updated daily.
-
Peers are sorted by market capitalisation and only details for the top 10 will be shown.
Total Shareholder Return
Period | Dividend Received | Capital Appreciation | Total Shareholder Return |
---|
Short Term Return |
5 Days |
- | -1.110 | | | -15.55 % |
10 Days |
- | -1.290 | | | -17.62 % |
20 Days |
- | +0.160 | | | +2.73 % |
Medium Term Return |
3 Months |
- | +1.590 | | | +35.81 % |
6 Months |
- | -0.635 | | | -9.53 % |
1 Year |
- | -1.770 | | | -22.69 % |
Long Term Return |
2 Years |
- | -4.470 | | | -42.57 % |
3 Years |
- | -86.400 | | | -93.48 % |
5 Years |
- | -1289.970 | | | -99.53 % |
Annualised Return |
Annualised |
- | - | | | -65.84 % |
Notes:
-
Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
-
Script dividends are ignored in this calculation.
Price Movements
1 Year Range |
2.112 - 13.000 |
Change From 1 Year Low |
+3.918 |
% Change From 1 Year Low (%) |
+185.51 |
Change From 1 Year High |
-6.970 |
% Change From 1 Year High (%) |
-53.62 |
2 Years Range |
2.112 - 21.100 |
Change From 2 Years Low |
+3.918 |
% Change From 2 Years Low (%) |
+185.51 |
Change From 2 Years High |
-15.070 |
% Change From 2 Years High (%) |
-71.42 |
5 Years Range |
2.112 - 1,692.000 |
Change From 5 Years Low |
+3.918 |
% Change From 5 Years Low (%) |
+185.51 |
Change From 5 Years High |
-1685.970 |
% Change From 5 Years High (%) |
-99.64 |
Notes:
Price movements are based on adjusted historical data.
Company Background
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
More Information Available
More information is available to our subscribers, including:
- Market Moving News from Dow Jones Newswires
- Consensus Estimates
- Dividend/Distribution History
- Financial Summary with Financial Period Comparison
- Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
- Events Calendar for Results Announcements, Ex-Dates etc
- Insider Buying and Selling Report
If you are an existing subscriber, please login. If not, read up on what
you are missing out in our Help Centre
and join us as a subscriber.
Disclaimer:
While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-
- no liability is accepted for any errors or inaccuracies resulting from your use of these features;
- many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.